Nuvalent (NUVL) Other Non-Current Assets (2021 - 2026)

Nuvalent (NUVL) reported Other Non-Current Assets of $23.2 million for Q1 2026, up 20.56% on a YoY basis from $19.3 million in Q1 2025, and up 14.46% quarter-over-quarter from $20.3 million in Q4 2025.

Nuvalent (NUVL) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Nuvalent has reported Other Non-Current Assets for 6 years, with the latest figure at $23.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 20.56% year-over-year to $23.2 million; the trailing twelve-month figure through Mar 2026 stood at $23.2 million (up 20.56% YoY), and the FY2025 full-year result was $20.3 million, up 117.96% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $23.2 million, up from $20.3 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $23.2 million in Q1 2026, with the low at $2.6 million in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $10.6 million across 5 years, with a median of $9.0 million in 2024.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets gained 18.03% — and 2025, when it soared 150.08%.
  • Nuvalent's Other Non-Current Assets stood at $4.5 million in 2022, then jumped by 31.96% to $5.9 million in 2023, then surged by 57.8% to $9.3 million in 2024, then surged by 117.96% to $20.3 million in 2025, then grew by 14.46% to $23.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $23.2 million (Q1 2026), $20.3 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Nuvalent 9.70 Bn 9.70 Bn - 23.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.21 Mn
Dec 31, 2025 20.28 Mn
Sep 30, 2025 22.97 Mn
Jun 30, 2025 20.93 Mn
Mar 31, 2025 19.25 Mn
Dec 31, 2024 9.30 Mn
Sep 30, 2024 9.18 Mn
Jun 30, 2024 8.97 Mn
Mar 31, 2024 8.97 Mn
Dec 31, 2023 5.90 Mn
Sep 30, 2023 5.31 Mn
Jun 30, 2023 4.96 Mn
Mar 31, 2023 4.70 Mn
Dec 31, 2022 4.47 Mn
Sep 30, 2022 4.31 Mn
Jun 30, 2022 4.20 Mn
Mar 31, 2022 2.57 Mn
Dec 31, 2021 3.20 Mn
Sep 30, 2021 2.83 Mn
Jun 30, 2021 2.50 Mn